This is a Validated Antibody Database (VAD) review about human IBSP, based on 6 published articles (read how Labome selects the articles), using IBSP antibody in all methods. It is aimed to help Labome visitors find the most suited IBSP antibody. Please note the number of articles fluctuates since newly identified citations are added and citations for discontinued catalog numbers are removed regularly.
IBSP synonym: BNSP; BSP; BSP-II; SP-II

Knockout validation
Invitrogen
domestic rabbit polyclonal
  • western blot knockout validation; human; fig 5b
  • immunohistochemistry; human; 1:100; fig 1l
Invitrogen IBSP antibody (Invitrogen, PA5-50633) was used in western blot knockout validation on human samples (fig 5b) and in immunohistochemistry on human samples at 1:100 (fig 1l). Nat Commun (2021) ncbi
Santa Cruz Biotechnology
mouse monoclonal (LFMb-24)
  • immunohistochemistry; human; 1:1000; fig 4c
Santa Cruz Biotechnology IBSP antibody (Santa Cruz Biotechnology, Sc-73634) was used in immunohistochemistry on human samples at 1:1000 (fig 4c). Cell Rep (2022) ncbi
mouse monoclonal (LFMb-25)
  • immunocytochemistry; human; 1:100; loading ...; fig 2a
  • immunohistochemistry; human; 1:100; loading ...; fig 1a
  • western blot; human; 1:500; loading ...; fig 4
Santa Cruz Biotechnology IBSP antibody (Santa Cruz, sc-73630) was used in immunocytochemistry on human samples at 1:100 (fig 2a), in immunohistochemistry on human samples at 1:100 (fig 1a) and in western blot on human samples at 1:500 (fig 4). J Histochem Cytochem (2017) ncbi
mouse monoclonal (LFMb-24)
  • western blot; human; loading ...; fig 2b
Santa Cruz Biotechnology IBSP antibody (Santa Cruz Biotechnology, sc-73634) was used in western blot on human samples (fig 2b). Biosci Trends (2016) ncbi
mouse monoclonal (LFMb-25)
  • immunohistochemistry - paraffin section; human; 1:100; loading ...; fig 2
  • western blot; human; 1:2500; loading ...; fig 3a
Santa Cruz Biotechnology IBSP antibody (Santa Cruz, sc-73630) was used in immunohistochemistry - paraffin section on human samples at 1:100 (fig 2) and in western blot on human samples at 1:2500 (fig 3a). Oncotarget (2016) ncbi
Invitrogen
domestic rabbit polyclonal
  • western blot knockout validation; human; fig 5b
  • immunohistochemistry; human; 1:100; fig 1l
Invitrogen IBSP antibody (Invitrogen, PA5-50633) was used in western blot knockout validation on human samples (fig 5b) and in immunohistochemistry on human samples at 1:100 (fig 1l). Nat Commun (2021) ncbi
Developmental Studies Hybridoma Bank
mouse monoclonal (WVID1(9C5))
  • immunocytochemistry; human; 1:1
Developmental Studies Hybridoma Bank IBSP antibody (DSHB, WVID1) was used in immunocytochemistry on human samples at 1:1. Anticancer Res (2004) ncbi
Articles Reviewed
  1. Ghochani Y, Muthukrishnan S, Sohrabi A, Kawaguchi R, Condro M, Bastola S, et al. A molecular interactome of the glioblastoma perivascular niche reveals integrin binding sialoprotein as a mediator of tumor cell migration. Cell Rep. 2022;41:111511 pubmed publisher
  2. Wu K, Feng J, Lyu F, Xing F, Sharma S, Liu Y, et al. Exosomal miR-19a and IBSP cooperate to induce osteolytic bone metastasis of estrogen receptor-positive breast cancer. Nat Commun. 2021;12:5196 pubmed publisher
  3. Hamilton S, Ferando B, Eapen A, Yu J, Joy A. Cancer Secretome May Influence BSP and DSP Expression in Human Salivary Gland Cells. J Histochem Cytochem. 2017;65:139-151 pubmed publisher
  4. Ozeki N, Mogi M, Hase N, Hiyama T, Yamaguchi H, Kawai R, et al. Polyphosphate-induced matrix metalloproteinase-13 is required for osteoblast-like cell differentiation in human adipose tissue derived mesenchymal stem cells. Biosci Trends. 2016;10:365-371 pubmed
  5. Anunobi C, Koli K, Saxena G, Banjo A, Ogbureke K. Expression of the SIBLINGs and their MMP partners in human benign and malignant prostate neoplasms. Oncotarget. 2016;7:48038-48049 pubmed publisher
  6. Pautke C, Schieker M, Tischer T, Kolk A, Neth P, Mutschler W, et al. Characterization of osteosarcoma cell lines MG-63, Saos-2 and U-2 OS in comparison to human osteoblasts. Anticancer Res. 2004;24:3743-8 pubmed